Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Digestive & Intestinal Remedies Market

Digestive & Intestinal Remedies Market Share

Report ID: GMI11167
Published Date: Sep 2024
Report Format: PDF

Download Free Sample

Digestive & Intestinal Remedies Market Share

The competitive landscape in the market is driven by presence of diverse companies’ multinational corporations as well as regional and local players. Companies are presently focusing on developing advanced formulations with longer-lasting effects, fewer side effects, and improved efficacy. They are heavily investing in research and development to introduce new products, such as advanced probiotics, specialized supplements, and natural remedies, to cater to evolving consumer demands. Established brands with a history of effectiveness and safety enjoy strong consumer loyalty, making it challenging for new entrants to gain market share.

Digestive & Intestinal Remedies Market Companies

Prominent players operating in the digestive & intestinal remedies industry include:

Abbott Laboratories
Bayer AG
C.H. Boehringer Sohn AG & Co. KG.
China Resources Pharmaceutical Group Limited
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Menarini Group
Merck & Co, Inc.
Pfizer Inc.
The Procter & Gamble Company
Reckitt Benckiser Group plc (RB)
Sanofi S.A.
Taisho Pharmaceutical Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The digestive & intestinal remedies market was valued at USD 19.5 billion in 2023 and will witness a 3.5% CAGR between 2024 and 2032 driven by the rising incidence of gastrointestinal disorders.

The digestive medicines segment in the digestive & intestinal remedies industry will attain USD 10.3 billion by 2032, due to its specifically formulated to alleviate various digestive issues.

North America digestive & intestinal remedies market was worth USD 8 billion in 2023 and is expected to surpass USD 10.8 billion by 2032, owing to the popularity of over the counter (OTC) digestive solutions.

Abbott Laboratories, Bayer AG, C.H. Boehringer Sohn AG & Co. KG., China Resources Pharmaceutical Group Limited, and Eli Lilly and Company, among others.